AzTrials
AzTrials

FeverNCT07145541

AION BIOSYSTEMS, INC. Tempshield for Continuous Tempreature Monitoring

A study testing Aion Tempshield Device in people with Fever and Sepsis, run by AION Biosystems at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this research study is to evaluate the effectiveness of the AION BIOSYTEMS, INC. tempshield ("Shield") temperature monitoring device and platform in detecting body temperature for children 2-4 years old. Read more about this study

Who is it for?
Ages 1 year to 4 years
Conditions the study is for
Fever, Sepsis
What is being tested?
Aion Tempshield Device
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
72 participants
Where
1 siteUnited States
Study dates
31 Jan 2024to 10 Oct 2024
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 year to 4 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Male or female patients between ages 1 years - 4 years of age
  • Confirmed oral temperature of >=99.5 F for febrile participants
  • Willing and likely (based on the investigator's judgement) to comply with all study requirements

Who cannot join

  • Participants who are allergic to silicone
  • Adolescents with sensory issues who may find it difficult to have a wearable device on their chest.
  • Participants presenting an anatomical limitation that would prevent the use of the wearable device

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Children's Hospital

    Washington D.C., District of Columbia, 20010

Other trials in United States

About this study

Official title: A Prospective, Interventional Study Assessing the Effectiveness of the AION BIOSYSTEMS, INC. TempShield ("Shield") for Continuous Temperature Monitoring Device in the Pediatric Emergency Depart

The purpose of this research study is to evaluate the effectiveness of the AION BIOSYTEMS, INC. tempshield ("Shield") temperature monitoring device and platform in detecting body temperature for children 2-4 years old. The ED Research team will be deploying this device on all qualified patients who are awaiting inpatient admission from the emergency department and who have consented to participating in the study. Patients will be asked to keep the device on for a maximum of 7 hours during their stay in the emergency department. There is a potential clinical benefit that fevers will be detected earlier in subjects wearing the AION BIOSTYEMS, INC. tempshield. It is hoped that information gained from the study will help assist clinical care workflow and the treatment of future patients.

Read the detailed description

A prospective, single site, interventional study assessing the effectiveness for use of the non-invasive wireless temperature monitoring device and platform in detecting body temperature of young children during 1st 7 hours of their stay in the emergency department for patients, between 2-4 years of age. The AION BIOSYSTEMS, INC. tempshield is a skin-applied, continuous temperature monitor. It is battery powered, communicates using Bluetooth LE to a smartphone, then to a clinician dashboard, and is designed to be worn continuously for up to 60 days. Its primary use is for patient monitoring in hospital or post-discharge from a healthcare facility. This study is designed as prospective, interventional study assessing the effectiveness of the AION BIOSYSTEMS, INC. tempshield ("Shield") for continuous temperature monitoring device in the Pediatric Emergency Department. Upon inpatient admission decision entry to the emergency department, a Children's National study staff will be approached for interest and presented with the project and all relevant study materials/documents.Through the tempshield system, clinicians can be notified if a patient's temperature exceeds a given threshold.

The tempshield system is centered around a non-invasive temperature sensor placed against the patient's skin, in the pectoral region just below the collar bone. The temperature sensor is held in place with a silicone adhesive tape similar to a custom shaped piece of medical tape. The silicone adhesive tape is hypoallergenic. Once enrolled, the tempshield wearable device will be placed on the upper chest with gentle, silicon adhesive tape. Study staff will ensure that the device is stable on the subject's chest. In the case that the device will not successfully adhere to the patient's chest, the research team will forego the enrollment of that specific subject due to lack of feasibility. The research team will register the wearable device and connect it to the AION BIOSYSTEMS, INC. Shield app via the Samsung A13. A Samsung phone will be kept in the patient's room to track the tempreature from the device. This phone is used for recording the Oral temperatures taken by the study staff.

Upon activation of the tempshield, participants will be given 60 minutes for the tempshield to acclimate to the environment before an oral temperature measurement is taken. The oral temperature will be taken by the research team using a Welch Allyn 901053 Oral Thermometer and input information into the AION BIOSYSTEMS, INC. app. After the acclimation period, the first measurement of oral temperature using the Welch Allyn oral thermometer will be recorded in the AION BIOSYSTEMS, INC. Shield app by the research team. Following this, measurements of the tempshield sensor temperature will be recorded in the AION BIOSYSTEMS, INC. Shield app 1 ±5 minutes apart. Research coordinators will measure oral temperatures every 2 hours ±1 hour for up to a 24hour period, with a maximum of 6 recordings per pt.. A patient's participation will end once they are discharged from the ED or after 7 hours, whichever comes first. If the patient is moved to in-patient unit, the research coordinator will remove the device from the participant. After 7 hours or at the time of ED discharge, the device will be removed from the participant. If there is no height listed in the EMR, research staff will measure participant height.

In addition to collecting oral temperature every 2 hours, research staff will also recheck placement of AION BIOSYSTEMS, INC. device in adhesive to ensure that the device is still stable in place. If adhesive is not stable, research staff will replace the adhesive with new strip. Research staff will check with LAR to make sure that device was not removed or did not fall off. If device was removed or had fallen off, research team will document estimated time of removal and replacement on CRF and the reasoning for the device displacement. If the device is damage and unable to be used, , the device will be replaced, and the enrollment will continue for the duration of the 7 hours. Otherwise, the same device will be used on the subject throughout the enrollment even if it falls off or is removed from the subject.

Conditions
Fever, Sepsis
Being tested
Aion Tempshield Device
Medical subject headings
Fever, Sepsis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Aion Tempshield DeviceDevice

    The AION BIOSYSTEMS, INC. tempshield is a skin-applied, continuous temperature monitor. It is battery powered, communicates using Bluetooth LE to a smartphone, then to a clinician dashboard, and is designed to be worn continuously for up to 60 days. Its primary use is for patient monitoring in hospital or post-discharge from a healthcare facility. Through the tempshield system, clinicians can be notified if a patient's temperature exceeds a given threshold. The tempshield system is centered around a non-invasive temperature sensor placed against the patient's skin, in the pectoral region just below the collar bone. The temperature sensor is held in place with a silicone adhesive tape similar to a custom shaped piece of medical tape. The silicone adhesive tape is hypoallergenic.

Study groups in NCT07145541
Study groupRoleWhat they receive
Aion Tempshield DeviceExperimentalNot described
Receives: Device: Aion Tempshield Device

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Difference in Temperature Reported by the AION Tempshield Compared to the Welch Allyn 901053 Electronic Thermometer

    Temperature from the study participants will be collected via the AION TempShield and the Welch Allyn 901053 electronic thermometer. The difference output measure was then calculated by subtracting the TempShield-reported temperature from the Welch Allyn temperature.

    I.e., outcome measure = Welch Allyn temperature - TempShield temperature

    Measured: 24 Hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Aug 2025
  2. Study start31 Jan 2024
  3. Primary completion10 Oct 2024
  4. Study completion10 Oct 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
72 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07145541
Sponsor's protocol ID
STUDY00000455
Status last verified
Nov 2025
First submitted
28 Jul 2025
Last updated
19 Nov 2025
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes

Questions about this trial

What is this clinical trial studying?

A study testing Aion Tempshield Device in people with Fever and Sepsis, run by AION Biosystems at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Nov 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 19 Nov 2025). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Difference in Temperature Reported by the AION Tempshield Compared to the Welch Allyn 901053 Electronic Thermometer (time frame: 24 Hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Nov 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in